Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/29/2013US8569456 Receptor activator of NF-kappaB
10/29/2013US8569455 Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7S globulin alfa' subunit involved in HEP G2 cell cholesterol homeostasis
10/29/2013US8569454 YS68 polypeptide involved in primitive hematopoiesis
10/29/2013US8569452 Preparation of phalloidin and its derivatives
10/29/2013US8569450 CD3 epsilon immunogens and antibodies
10/29/2013US8569448 NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders
10/29/2013US8569447 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
10/29/2013US8569446 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/29/2013US8569445 Secreted proteins
10/29/2013US8569347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
10/29/2013US8569332 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/29/2013US8569286 Notch pathway signaling inhibitor compound
10/29/2013US8569253 Methods and compositions for gene inactivation
10/29/2013US8569246 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
10/29/2013US8569245 Protease inhibitors, compositions and methods of use
10/29/2013US8569244 FOXM1 peptide and medicinal agent comprising the same
10/29/2013US8569243 Sirtuin 6 activating peptides and cosmetic or pharmaceutical composition containing them
10/29/2013US8569241 Composition for improving brain function and method for improving brain function
10/29/2013US8569240 Methods of preventing or treating brain diseases
10/29/2013US8569238 Plasma protein effective for suppressing cough
10/29/2013US8569237 Chimeric hirudin proteins
10/29/2013US8569236 Resuscitation fluid
10/29/2013US8569235 Treatment of kidney disorders with VIP fragments
10/29/2013US8569234 Compositions and methods for including melanogenesis in a subject
10/29/2013US8569233 Modified animal erythropoietin polypeptides and their uses
10/29/2013US8569232 Therapeutic agent for diabetes
10/29/2013US8569231 Soluble non-depot insulin conjugates and uses thereof
10/29/2013US8569230 Antimicrobial kinocidin compositions and methods of use
10/29/2013US8569229 Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
10/29/2013US8569228 Compositions comprising enzyme-cleavable oxycodone prodrug
10/29/2013US8569227 Stabilized fibronectin domain compositions, methods and uses
10/29/2013US8569226 High affinity metal-oxide binding peptides with reversible binding
10/29/2013US8569005 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
10/29/2013US8568985 Breast endothelial cell expression patterns
10/29/2013US8568967 Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
10/29/2013US8568786 Method and compositions for polymer nanocarriers containing therapeutic molecules
10/29/2013US8568781 Peptide-carrying nanoparticles
10/29/2013US8568766 Peptides and peptide mimetics to treat pathologies associated with eye disease
10/29/2013US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof
10/29/2013US8568745 Water-soluble drug carrier and process for producing the same
10/29/2013US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides
10/29/2013US8568741 Botulinum toxin for smoking cessation
10/29/2013US8568740 Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
10/29/2013US8568737 Screening methods using G-protein coupled receptors and related compositions
10/29/2013US8568736 Polypeptide derivatives of parathyroid hormone (PTH)
10/29/2013US8568734 Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
10/29/2013US8568733 HER-2/neu fusion proteins
10/29/2013US8568720 High concentration antibody-containing liquid formulation
10/29/2013US8568716 Kit comprising elastase
10/29/2013US8568715 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
10/29/2013US8568714 Lys K endolysin is synergistic with lysostaphin against MRSA
10/29/2013US8568713 Super fast-acting insulin compositions
10/29/2013US8568712 Enzyme and prebiotic combinations for enhancing probiotic efficacy
10/29/2013US8568711 Antimicrobial compositions
10/29/2013US8568708 Tumor-specific delivery of therapeutic agents via liposomase
10/29/2013US8568706 Modified human interferon-beta polypeptides
10/29/2013US8568698 Methods and materials for providing teeth with a white appearance
10/29/2013US8568691 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning
10/29/2013CA2731177C Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
10/29/2013CA2709545C Topical application and formulation of erythropoietin for skin wound healing
10/29/2013CA2558615C Azabicyclo-octane inhibitors of iap
10/29/2013CA2549409C Glycopegylated granulocyte colony stimulating factor
10/29/2013CA2546619C Il-23 and its receptor; related reagents and methods
10/29/2013CA2488968C Peptides for regulation of urokinase (upa) and tissue type (tpa) plasminogen activator and method of optimizing therapeutic efficacy
10/29/2013CA2481952C Immunological methods and compositions for the treatment of alzheimer's disease
10/29/2013CA2469134C Novel peptide and pharmaceutical use of the same
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2446408C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/29/2013CA2442363C Reducing the immunogenicity of fusion proteins
10/29/2013CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/29/2013CA2396992C Hybrid cells
10/29/2013CA2375467C Antisense therapy for hormone-regulated tumors
10/29/2013CA2371794C Human antibiotic proteins
10/26/2013CA2814180A1 Preserving method of growth factors derived from platelets
10/24/2013WO2013159051A1 Morpholino-mediated increase in soluble flt-1 expression results in decreased ocular and tumor neovascularization
10/24/2013WO2013159021A1 Engineered collagen binding mscramm with enhanced affinity for collagen
10/24/2013WO2013158959A1 Compositions and methods for treatment of graft-versus-host disease
10/24/2013WO2013158871A1 Use of erythropoietin and derivatives for treating hypertension
10/24/2013WO2013158800A1 Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof
10/24/2013WO2013158773A2 Rnase 7 antimicrobial peptides
10/24/2013WO2013158739A1 Neuroprotective composition and method of use
10/24/2013WO2013158661A1 Ocular drug delivery system
10/24/2013WO2013158618A1 Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
10/24/2013WO2013158617A1 Endostatin peptides and use thereof
10/24/2013WO2013158600A1 Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
10/24/2013WO2013158328A1 Methods for stimulating hair growth
10/24/2013WO2013158296A1 Method of treating an ocular disease and compositions effective for treating an ocular disease
10/24/2013WO2013158292A1 Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof
10/24/2013WO2013158263A1 Replication-competent vesicular stomatitis viruses
10/24/2013WO2013158256A2 Immunomodulation by anti-cd3 immunotoxins to treat cancers not uniformly bearing surface cd3
10/24/2013WO2013157961A1 Immunostimulatory compositions and methods of manufacture
10/24/2013WO2013157410A1 Fzd10-binding peptide
10/24/2013WO2013157003A1 Growth enhancement of infants
10/24/2013WO2013157002A1 Long-acting oxyntomodulin variants and methods of producing same
10/24/2013WO2013156955A1 Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (adhd)
10/24/2013WO2013156920A1 Klotho variant polypeptides and uses thereof in therapy
10/24/2013WO2013156525A1 New process for the production and purification of the collagenase enzyme from vibrio alginolyticus
10/24/2013WO2013156493A1 Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/24/2013WO2013156031A2 SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 3163